{
    "title": "To amend title XVIII of the Social Security Act, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide additional beneficiary protections.",
    "content": "SECTION 1. SHORT TITLE; TABLE OF CONTENTS.\n\n    (a) Short Title.--This Act may be cited as the ``Preserving \nMedicare for All Act of 2004''.\n    (b) Table of Contents.--The table of contents of this Act is as \nfollows:\n\nSec. 1. Short title; table of contents.\nSec. 2. Authority to negotiate prices.\nSec. 3. Guaranteed prescription drug benefits.\nSec. 4. Full reimbursement for qualified retiree prescription drug \n                            plans.\nSec. 5. Repeal of Comparative Cost Adjustment (CCA) program.\nSec. 6. Repeal of MA Regional Plan Stabilization Fund.\nSec. 7. Repeal of cost containment provisions.\n\nSEC. 2. AUTHORITY TO NEGOTIATE PRICES.\n\n    Subsection (i) of section 1860D-11, as added by section 101 of the \nMedicare Prescription Drug, Improvement, and Modernization Act of 2003 \n(Public Law 108-173), is repealed.\n\nSEC. 3. GUARANTEED PRESCRIPTION DRUG BENEFITS.\n\n    (a) In General.--Section 1860D-3 of the Social Security Act, as \nadded by section 101 of the Medicare Prescription Drug, Improvement, \nand Modernization Act of 2003 (Public Law 108-173), is amended to read \nas follows:\n\n      ``access to a choice of qualified prescription drug coverage\n\n    ``Sec. 1860D-3. (a) Assuring Access to a Choice of Coverage.--\n            ``(1) Choice of at least three plans in each area.--The \n        Secretary shall ensure that each part D eligible individual has \n        available, consistent with paragraph (2), a choice of \n        enrollment in--\n                    ``(A) a nationwide prescription drug plan offered \n                by the Secretary in accordance with subsection (b); and\n                    ``(B) at least 2 qualifying plans (as defined in \n                paragraph (3)) in the area in which the individual \n                resides, at least one of which is a prescription drug \n                plan.\n            ``(2) Requirement for different plan sponsors.--The \n        requirement in paragraph (1)(B) is not satisfied with respect \n        to an area if only one entity offers all the qualifying plans \n        in the area.\n            ``(3) Qualifying plan defined.--For purposes of this \n        section, the term `qualifying plan' means--\n                    ``(A) a prescription drug plan;\n                    ``(B) an MA-PD plan described in section \n                1851(a)(2)(A)(i) that provides--\n                            ``(i) basic prescription drug coverage; or\n                            ``(ii) qualified prescription drug coverage \n                        that provides supplemental prescription drug \n                        coverage so long as there is no MA monthly \n                        supplemental beneficiary premium applied under \n                        the plan, due to the application of a credit \n                        against such premium of a rebate under section \n                        1854(b)(1)(C); or\n                    ``(C) a nationwide prescription drug plan offered \n                by the Secretary in accordance with subsection (b).\n    ``(b) HHS as PDP Sponsor for a Nationwide Prescription Drug Plan.--\n            ``(1) In general.--The Secretary, through the Administrator \n        of the Centers for Medicare & Medicaid Services, shall take \n        such steps as may be necessary to qualify and serve as a PDP \n        sponsor and to offer a prescription drug plan that offers basic \n        prescription drug coverage throughout the United States. Such a \n        plan shall be in addition to, and not in lieu of, other \n        prescription drug plans offered under this part.\n            ``(2) Premium; solvency; authorities.--In carrying out \n        paragraph (1), the Secretary--\n                    ``(A) shall establish a premium in the amount of \n                $35 for months in 2006 and, for months in subsequent \n                years, in the amount specified in this paragraph for \n                months in the previous year increased by the annual \n                percentage increase described in section 1860D-2(b)(6) \n                (relating to growth in medicare prescription drug costs \n                per beneficiary) for the year involved;\n                    ``(B) is deemed to have met any applicable solvency \n                and capital adequacy standards; and\n                    ``(C) shall exercise such authorities (including \n                the use of regional or other pharmaceutical benefit \n                managers) as the Secretary determines necessary to \n                offer the prescription drug plan in the same or a \n                comparable manner as is the case for prescription drug \n                plans offered by private PDP sponsors.\n    ``(c) Flexibility in Risk Assumed.--In order to ensure access \npursuant to subsection (a) in an area the Secretary may approve limited \nrisk plans under section 1860D-11(f) for the area.''.\n    (b) Conforming Amendment.--Section 1860D-11 of the Social Security \nAct, as added by section 101 of the Medicare Prescription Drug, \nImprovement, and Modernization Act of 2003 (Public Law 108-173), is \namended by striking subsection (g).\n\nSEC. 4. FULL REIMBURSEMENT FOR QUALIFIED RETIREE PRESCRIPTION DRUG \n              PLANS.\n\n    (a) Elimination of True Out-Of-Pocket Limitation.--Section 1860D-\n2(b)(4)(C)(ii) of the Social Security Act, as added by section 101(a) \nof the Medicare Prescription Drug, Improvement, and Modernization Act \nof 2003 (Public Law 108-173), is amended--\n            (1) by inserting ``under a qualified retiree prescription \n        drug plan (as defined in section 1860D-22(a)(2)),'' after \n        ``under section 1860D-14,''; and\n            (2) by inserting ``, under such a qualified retiree \n        prescription drug plan,'' after ``(other than under such \n        section'' .\n    (b) Equalization of Subsidies.--Notwithstanding any other provision \nof law, the Secretary of Health and Human Services shall provide for \nsuch increase in the special subsidy payment amounts under section \n1860D-22(a)(3) of the Social Security Act, as added by section 101(a) \nof the Medicare Prescription Drug, Improvement, and Modernization Act \nof 2003 (Public Law 108-173), as may be appropriate to provide for \npayments in the aggregate equivalent to the payments that would have \nbeen made under section 1860D-15 of such Act if the individuals were \nnot enrolled in a qualified retiree prescription drug plan. In making \nsuch computation, the Secretary shall not take into account the \napplication of the amendments made by section 1202 of the Medicare \nPrescription Drug, Improvement, and Modernization Act of 2003.\n\nSEC. 5. REPEAL OF COMPARATIVE COST ADJUSTMENT (CCA) PROGRAM.\n\n    Subtitle E of title II of the Medicare Prescription Drug, \nImprovement, and Modernization Act of 2003 (Public Law 108-173), and \nthe amendments made by such subtitle, are repealed.\n\nSEC. 6. REPEAL OF MA REGIONAL PLAN STABILIZATION FUND.\n\n    (a) In General.--Section 1858 of the Social Security Act, as added \nby section 221(c) of the Medicare Prescription Drug, Improvement, and \nModernization Act of 2003 (Public Law 108-173), is amended--\n            (1) by striking subsection (e);\n            (2) by redesignating subsections (f), (g), and (h) as \n        subsections (e), (f), and (g), respectively; and\n            (3) in subsection (e), as so redesignated, by striking \n        ``subject to subsection (e),''.\n    (b) Conforming Amendment.--Section 1851(i)(2) of the Social \nSecurity Act (42 U.S.C. 1395w-21(i)(2)), as amended by section \n221(d)(5) of the Medicare Prescription Drug, Improvement, and \nModernization Act of 2003 (Public Law 108-173), is amended by striking \n``1858(h)'' and inserting ``1858(g)''.\n\nSEC. 7. REPEAL OF COST CONTAINMENT PROVISIONS.\n\n    Subtitle A of title VIII of the Medicare Prescription Drug, \nImprovement, and Modernization Act of 2003 (Public Law 108-173) is \nrepealed and any provisions of law amended by such subtitle are \nrestored as if such subtitle had not been enacted."
}